Browse Category

Investments News 11 November 2025 - 14 November 2025

Luxembourg Goes Full Bitcoin: First Eurozone Sovereign Wealth Fund Puts 1% Into BTC as Europe Tests Central Bank Crypto

Luxembourg Goes Full Bitcoin: First Eurozone Sovereign Wealth Fund Puts 1% Into BTC as Europe Tests Central Bank Crypto

Luxembourg’s 1% Bitcoin Bet: Small Slice, Huge Signal Luxembourg has confirmed that its Intergenerational Sovereign Wealth Fund (FSIL) now holds 1% of its portfolio in Bitcoin, roughly €7 million out of about €700–730 million in assets. coinpaprika.com+2Luxembourg for Finance+2 The move stems from a July 2025 policy revision that lets FSIL allocate up to 15% of its holdings to “alternative investments” such as private equity, real estate, and digital assets. Bitcoin is the first crypto asset to make the cut. Luxembourg for Finance+2Goodwin Law Firm+2 According to official and legal briefings: In other words, Luxembourg hasn’t gone “all‑in” on BTC
14 November 2025
Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health, Inc. (NYSE: HIMS) is in the spotlight today after officially rolling out its new “Labs” diagnostic platform in partnership with Quest Diagnostics, even as the stock trades sharply lower and Wall Street sentiment turns more cautious. The telehealth company is trying to push deeper into preventive, data-led healthcare at the same time investors are digesting rich valuations, insider selling and tighter 2025 guidance. Investing.com+4Hims Investors+4Investing.com Australia+4 HIMS stock today: price, move and context As of early afternoon on Friday, November 14, 2025, Hims & Hers shares are: Trading has been volatile around HIMS in recent sessions,
Pfizer Stock Surges 15% on Trump’s Pricing Pact & $7.3B Obesity Deal – Can the Rally Last?

Pfizer Stock (PFE) Before the Bell on November 14, 2025: Metsera Deal Closes, BioNTech Stake Cut and Guidance Raised

As Wall Street heads into Friday’s session, Pfizer stock is trading slightly lower in premarket action while investors digest a trio of big developments: the completed acquisition of obesity‑drug developer Metsera, a sharp reduction in Pfizer’s stake in BioNTech, and a recent earnings report that lifted 2025 profit guidance but confirmed that COVID revenue continues to fade. Pfizer+2BioSpace+2 Benzinga’s real‑time quote shows Pfizer (NYSE: PFE) around $25.6 ahead of the U.S. market open, roughly 1% belowThursday’s close of $25.79, putting the shares on track for a mildly negative start to the day. Benzinga+1 Below is what traders and long‑term investors should know before the
Circle Internet Group (CRCL) Stock Today: JPMorgan Upgrade, Ark Invest Buy-the-Dip and New StableFX Launch Shape Post‑Earnings Rebound

Circle Internet Group (CRCL) Stock Today: JPMorgan Upgrade, Ark Invest Buy-the-Dip and New StableFX Launch Shape Post‑Earnings Rebound

Circle Internet Group (NYSE: CRCL), issuer of the USDC stablecoin, is back in focus today after a bruising post‑earnings sell‑off. As of this afternoon on 13 November 2025, CRCL is trading around $86.44, with an intraday range roughly between $83.94 and $88.81 and heavy volume of about 29 million shares, more than double typical trading activity. Investing.com Investors are digesting three big storylines: CRCL Stock Tries to Find a Floor After 12% Plunge Circle’s stock has had a wild 24 hours. On Wednesday, 12 November, CRCL dropped around 12% to close at $86.30, its steepest single‑day fall since late June
13 November 2025
Manulife (MFC.TO) Hits Record High on Q3 Beat, India Mahindra JV and $350M Longevity Push

Manulife (MFC.TO) Hits Record High on Q3 Beat, India Mahindra JV and $350M Longevity Push

Manulife Financial Corporation (TSX: MFC, NYSE: MFC) has packed a full strategic reset, fresh Asian expansion, and a record quarter of earnings momentum into just a couple of days — and the market is cheering. Shares of Manulife jumped as much as 3.3% today to an all‑time high of C$49.82 in Toronto after the Canadian insurer beat Q3 estimates, unveiled a refreshed growth strategy, and confirmed a 50:50 life‑insurance joint venture in India with Mahindra & Mahindra. Reuters+1 Below is a full rundown of everything investors need to know about Manulife’s news flow around 13 November 2025 — from earnings
13 November 2025
SoFi Technologies (SOFI) Today — Nov. 7, 2025: Shares Ease After Big Run as Fresh Analyst Takes, New Forecasts and “Risk Reduction” Move Make Headlines

SOFI Stock Today (13 November 2025): Shares Rise ~4% as SoFi CFO Discloses Prepaid Variable Forward; Fresh Form 144 and New Fund Stake Surface

Dateline: 13 November 2025 SoFi Technologies (NASDAQ: SOFI) traded higher today, up around 4% to $32.21 as of 12:05 UTC, with traders digesting fresh insider filings and continued follow‑through from this week’s product news. Key takeaways for 13.11.2025 What the filings mean Prepaid variable forward (PVF) ≠ open‑market sale.PVFs are commonly used by executives to access liquidity or hedge concentrated exposure without immediately selling shares. Under Lapointe’s PVF, the number of shares ultimately delivered (or the cash paid) in 2027 will depend on SOFI’s stock price relative to the contract’s floor ($25.38) and cap ($50.58); he retains voting and dividend
E.ON Confirms 2025 Outlook as Grid Investments Lift Nine‑Month EBITDA 10% to €7.4bn

E.ON Confirms 2025 Outlook as Grid Investments Lift Nine‑Month EBITDA 10% to €7.4bn

Frankfurt — November 12, 2025 (12.11.2025). E.ON said today that heavy spending on its electricity networks continued to pay off in the first nine months of 2025, with adjusted Group EBITDA up 10% to €7.4 billion and adjusted Group net income up 4% to €2.3 billion. The company kept its full‑year guidance in place as investment rose and the core networks business remained the main profit driver.  Reuters+1 Key numbers at a glance E.ON reiterated that it expects to meet its 2025 targets, including adjusted EBITDA of €9.6–€9.8 billion and adjusted net income of €2.85–€3.05 billion for the full year. The company’s total investments reached
12 November 2025
Ireland Stocks Today: ISEQ Edges Higher Near Record as Banks Lead, State Exits AIB; Ryanair Profit Boom Lifts Sentiment

Ireland Stocks Today: ISEQ Edges Higher Near Record as Banks Lead, State Exits AIB; Ryanair Profit Boom Lifts Sentiment

Dublin market wrap for Wednesday, 12 November 2025 DUBLIN — Nov 12, 2025. Ireland’s ISEQ All-Share Index nudged higher, building on last week’s breakout to fresh territory. The benchmark closed at 12,518.08, up 0.3% on Wednesday after a 1.5% jump on Tuesday, extending a November rally powered by financials and travel. The index’s advance keeps it within sight of its recent peak and consolidates gains set earlier this month.  Investing.com+1 Why it matters: The ISEQ’s autumn surge has come even as Dublin has lost several heavyweight listings in the past two years, underscoring the market’s resilience and the outsized role now played by domestically focused lenders and
12 November 2025
Vor Biopharma (VOR) Prices $100M Stock Offering at $10; Shares Slide as Investors Weigh Dilution — Nov. 11, 2025

Vor Biopharma (VOR) Prices $100M Stock Offering at $10; Shares Slide as Investors Weigh Dilution — Nov. 11, 2025

What happened today Vor Biopharma Inc. (NASDAQ: VOR) priced an underwritten public offering of 10 million common shares at $10.00 per share for $100 million in expected gross proceeds. The company granted underwriters a 30‑day option to purchase up to 1.5 million additional shares. Vor expects the transaction to close on or about Wednesday, Nov. 12, 2025, subject to customary conditions. J.P. Morgan, Jefferies, Citigroup, and TD Cowen are joint book‑running managers. The deal is being made under a shelf registration declared effective on March 31, 2025; a final prospectus supplement will be filed with the SEC. GlobeNewswire+1 How the
11 November 2025
Brookfield Renewable (BEP) Slides After $650M Equity Raise: Proceeds Target Isagen Stake & Baseload Growth (11/11/2025)

Brookfield Renewable (BEP) Slides After $650M Equity Raise: Proceeds Target Isagen Stake & Baseload Growth (11/11/2025)

Brookfield Renewable Partners L.P. (NYSE: BEP; TSX: BEP.UN) traded lower today after unveiling a fresh equity financing package tied to its push into “firm” clean power—including hydro and nuclear—and the recently completed increase in its stake in Colombia’s Isagen. Here’s what changed today, why it matters, and what’s next for investors. Key takeaways What happened today BEP units fell in morning trading after Monday’s after‑hours weakness, with market desks citing dilution from a new unit sale. Coverage noted the decline was linked to the US$650M capital raise unveiled the prior evening. MarketWatch+1 On the TSX, MarketWatch reported the Canadian line
11 November 2025
Supply@ME Capital (LON: SYME) today — 11 Nov 2025: No new RNS; AGM confirmed for 4 Dec as shares trade around 0.004p

Supply@ME Capital (LON: SYME) today — 11 Nov 2025: No new RNS; AGM confirmed for 4 Dec as shares trade around 0.004p

Updated Tuesday, 11 November 2025 (UK time). Key takeaways Share price today (11 Nov 2025) In mid‑session dealing, SYME traded around 0.004p, with bid/ask at 0.003p/0.005p and an intraday range of 0.0035p to 0.0045p. Reported turnover was ~629.7 million shares. London South East data (delayed) also shows a wide spread typical of micro‑cap liquidity. Recent prints included trades time‑stamped around 14:55 UK time. London South East For perspective, the page lists a 52‑week range of 0.0015p–0.016p and ~71.73bn shares in issue, implying a market cap c. £2.9m at today’s quoted levels. London South East Note: Live prices on free sites
Caledonian Holdings (CHP.L) pops on 11 November: price crosses key averages; no new RNS as AlbaCo deal continues to set the tone

Caledonian Holdings (CHP.L) pops on 11 November: price crosses key averages; no new RNS as AlbaCo deal continues to set the tone

Dateline: London — 11 November 2025 (14:50 GMT) Summary: Micro‑cap investor Caledonian Holdings plc (AIM: CHP) traded firmly higher today, with the share price up around 33% to 0.004p by mid‑afternoon. The move came without any fresh regulatory announcements; instead, momentum appears to reflect the market’s ongoing digestion of October’s AlbaCo share‑swap and last week’s admission of 12.5 billion new shares, alongside a buoyant London market on rate‑cut hopes. FT Markets+2Investegate+2 Key takeaways for 11 Nov 2025 What moved CHP.L today Technical tailwinds. With no new company‑specific news, traders focused on tape action. CHP printed 0.004p (+33% vs. prior close), with
11 November 2025
Go toTop